×

Pipeline

Aptamer Sciences has launched the world’s first lung cancer early diagnosis kit based on AptoMIA technology.
Now we are expending our diagnostic kit development for many other diseases in collaboration with clinical institutions.

Bead Microarray

Indication Aptamer discovery Assay development Confirmatory clinical Trial RA Remarks
Lung Cancer         Manufacturing class III medical device approval from ministry of food and drug safety
Pancreatic Cancer          

Multiplex-PCR

Indication Aptamer discovery Assay development Confirmatory clinical Trial RA Remarks
Diabetic Retinopathy          
Pre-eclampsia          
Radiation treatment tolerance          
TOP